
    
      A total of 66 patients (aged 40-69) with knee osteoarthritis were randomized into two
      treatment groups to receive either duloxetine 60mg/day or pregabalin 300mg/day. The patients
      were evaluated before and one month after treatment and three months after treatment using
      the visual analog scale (VAS-pain), Neuropathic Pain Diagnostic Questionnaire (DN4), Short
      Form-36 (SF-36) Questionnaire, Western Ontario and McMaster University Osteoarthritis İndeks
      (WOMAC), Beck Depression Scale (BDS), Beck Anxiety Akalası (BAS), Pittsburg Sleep Quality
      Index (PSQI).
    
  